Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (71-80 of 760) with videos related to

Pageof 76
Sort By:
JACC. Cardiovascular Interventions|December 7, 2019
Reply: Therapeutic Window of P2Y<sub>12</sub> Inhibition: Should the Current Limits Be Modified?Dirk Sibbing, Dominick J Angiolillo
Expert Opinion on Therapeutic Targets|February 5, 2024
Role of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategiesMattia Galli, Dominick J Angiolillo
JACC. Cardiovascular Interventions|September 20, 2020
Duration of Dual Antiplatelet Therapy After PCI: How Short Can We Go?Usman Baber, Dominick J Angiolillo
Expert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J Angiolillo
The American Journal of Cardiology|March 12, 2021
Aspirin for Primary Prevention of Cardiovascular Disease in the 21<sup>st</sup> Century: A Review of the EvidenceDominick J Angiolillo, Davide Capodanno
Frontiers in Cardiovascular Medicine|September 12, 2022
De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?Mattia Galli, Dominick J Angiolillo
Evidence-Based Cardiovascular Medicine|June 7, 2006
Clopidogrel for up to one year after PCI is cost-effective for people with acute coronary syndromesDominick J Angiolillo, Debbie Singh
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 24, 2022
Dual Versus Triple Antithrombotic Therapy for Atrial Fibrillation-ACS/PCI: One Size Does Not Fit AllMattia Galli, Dominick J Angiolillo
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|December 11, 2003
[Past, present, and future of intracoronary brachytherapy]Dominick J Angiolillo, Manel Sabaté
JACC. Cardiovascular Interventions|May 22, 2017
Triple Antithrombotic Therapy at the Intercept Between Threats and Opportunities: Don't Throw Out the Baby With the Bath WaterDavide Capodanno, Dominick J Angiolillo
Pageof 76

Showing results (71-80 of 760) with videos related to

Sort By:
Pageof 76
JACC. Cardiovascular Interventions|December 7, 2019
Reply: Therapeutic Window of P2Y<sub>12</sub> Inhibition: Should the Current Limits Be Modified?Dirk Sibbing, Dominick J Angiolillo
Expert Opinion on Therapeutic Targets|February 5, 2024
Role of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategiesMattia Galli, Dominick J Angiolillo
JACC. Cardiovascular Interventions|September 20, 2020
Duration of Dual Antiplatelet Therapy After PCI: How Short Can We Go?Usman Baber, Dominick J Angiolillo
Expert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J Angiolillo
The American Journal of Cardiology|March 12, 2021
Aspirin for Primary Prevention of Cardiovascular Disease in the 21<sup>st</sup> Century: A Review of the EvidenceDominick J Angiolillo, Davide Capodanno
Frontiers in Cardiovascular Medicine|September 12, 2022
De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?Mattia Galli, Dominick J Angiolillo
Evidence-Based Cardiovascular Medicine|June 7, 2006
Clopidogrel for up to one year after PCI is cost-effective for people with acute coronary syndromesDominick J Angiolillo, Debbie Singh
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 24, 2022
Dual Versus Triple Antithrombotic Therapy for Atrial Fibrillation-ACS/PCI: One Size Does Not Fit AllMattia Galli, Dominick J Angiolillo
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|December 11, 2003
[Past, present, and future of intracoronary brachytherapy]Dominick J Angiolillo, Manel Sabaté
JACC. Cardiovascular Interventions|May 22, 2017
Triple Antithrombotic Therapy at the Intercept Between Threats and Opportunities: Don't Throw Out the Baby With the Bath WaterDavide Capodanno, Dominick J Angiolillo
Pageof 76